Ann: Intiger Confirms Strategic Focus on Fintech Advice Solutions, page-93

First 93 Last

Share
Profile

Follow
Beard_of_Zeus

3,972 Posts.

373

15/05/18

10:50

Post #: 33098563
Share

Originally posted by elphamale ↑

Ahh yes, those dangling golden carrots otherwise referred to as M1-M4.

I'll admit that back in 2016 I fell for the dream hook, line and sinker. I mean after all, what would the market cap look like with a $10 - $40m NET PROFIT representing the bottom line? The dream was kept alive throughout 2017 when PC and MF on several occasions (including the investor 2017 roadshow) maintained that they were still on track to achieve these milestones. However not long after that event I became very wary of management as their confidence, extremely positive dialogue (some call it fluff) simply wasn't translating into actual numbers.

Fast forward 7 months (here we are in the middle of 2018 already) and with little more than 12 months remaining on the clock (i.e. until those milestones lapse) the company has announced that it has closed its Sydney and India offices, shed local staff, is STILL essentially f*rt*ssing about with it's platform to meet the needs of CBA as the original version (BOOM) and initial launch of BOOM2 clearly failed to cut the mustard as a complete solution for 'prospective' clients, and continues to post disappointing quarterly results that can only suggest that the company is facing a very different reality to the milestone pipe dream (particularly M3-M4) that was sold to so many of us over the last couple of years.

Thus the roulette wheel has all bets placed on CBA and this feels to me like an eggs in one basket / do or die type strategy. With receipts of just $127k last quarter (operating deficit of $690k), the expectation that the current LOI with CBA will ultimately translate into a longstanding commercial deal IMO already been factored in to the current market cap of @$40m, and therefore CBA pulling the pin at anytime would IMO be nothing short of catastrophic for investors still living in hope that one day the IAM dream will become a reality.

GLTA

Expand

So if the CBA deal falls over that will be bad?

And if it doesn't, that would be good?

Mind blown.

IAM Price at posting: 2.2¢ Sentiment: Buy Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

COB

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

OJC

SPC to merge with Original Juice Co and Nature One Dairy

There are more pages in this discussion • 59 more messages in this thread...

First 93 Last

Add CF1 (ASX) to my watchlist

(20min delay)
Last 2.0¢		Change -0.002(9.09%)		Mkt cap ! $11.43M

Open	High	Low	Value	Volume
2.2¢	2.2¢	2.0¢	$23.09K	1.116M

Buyers (Bids)

No.	Vol.	Price($)
1	491617	2.0¢

Sellers (Offers)

Price($)	Vol.	No.
2.2¢	200000	1

View Market Depth

No.	Vol.	Price($)
1	491617	0.020
1	2772	0.019
3	1434231	0.018
1	1000000	0.017
1	1000000	0.016

Price($)	Vol.	No.
0.022	200000	1
0.024	125000	1
0.026	64744	1
0.030	827135	4
0.040	100000	1

Last trade - 15.01pm 02/10/2024 (20 minute delay)

CF1 (ASX) Chart

Ann: Intiger Confirms Strategic Focus on Fintech Advice Solutions, page-93

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SPC to merge with Original Juice Co and Nature One Dairy

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Intiger Confirms Strategic Focus on Fintech Advice Solutions, page-93

Top Stories

Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

SPC to merge with Original Juice Co and Nature One Dairy

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News